Molecular and Genomic Profiling of Head and Neck Tumors

StatusRecruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv21
  2. Trial status: Suspended to Recruiting
    • Primary and study completion dates: Dec 2025 to Dec 2030
    • Start date: May 2002 to Oct 1, 2002
    • Site details revised
    v20
  3. Trial status: Recruiting to Suspended Sponsor's reason: IRB approval has lapsed. Study suspended until it has been recertified by the IRB.
    • Site details revised
    • Collaborators: 2 to 3
    v19
  4. Study completion date: Dec 1, 2025 to Dec 2025v18
  5. 2 versions Re-verified since Feb 17, 2022, no change to tracked fieldsv16-v17
Show 14 earlier versionsHide 14 earlier versions
  1. Enrollment target: 400 to 1000
    • Primary completion date: Dec 2020 to Dec 2025
    • Study completion date: Dec 1, 2020 to Dec 1, 2025
    • Study site revised
    v15
  2. Primary completion date: May 2020 to Dec 2020
    • Study completion date: May 1, 2020 to Dec 1, 2020
    v14
  3. 2 versions Re-verified since Jul 30, 2018, no change to tracked fieldsv12-v13
  4. Study completion date: May 1, 2020v11
  5. Primary completion date: May 2016 to May 2020
    • Site contact updated
    • Collaborators: 1 to 2
    v10
  6. Re-verified, no change to tracked fieldsv9
  7. Primary completion date: May 2013 to May 2016v8 Show 4 more changesShow less
    • Study completion date: Mar 2015 to not stated
    • Study description expanded, about 16 words
    • Site contact updated
    • Study title shortened, about 9 words
  8. 5 versions Re-verified since May 20, 2008, no change to tracked fieldsv3-v7
  9. Enrollment target: 200 to 400v2 Show 5 more changesShow less
    • Primary completion date: May 2013
    • Study completion date: Mar 2005 to Mar 2015
    • Eligibility criteria expanded, about 15 words
    • Study description shortened, about 26 words
    • Study title shortened, about 2 words
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to study the genetic profile of head and neck tumors and their relationship to treatment response and outcome
Trial Details
NCT Number NCT00200486
Lead Sponsor Montefiore Medical Center
Collaborators: National Institutes of Health (NIH), National Institute of Dental and Craniofacial Research (NIDCR), National Cancer Institute (NCI)
Conditions
(from sponsor)		 Head and Neck Neoplasms
Related terms Head and Neck Neoplasms
Enrollment 1,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov